INIS
cancer
100%
patients
60%
combined therapy
38%
carcinomas
34%
data
34%
doses
28%
tumors
25%
diseases
23%
tissues
21%
image processing
20%
therapy
20%
protons
20%
validation
20%
values
20%
platinum
20%
testing
15%
datasets
14%
humans
13%
correlations
13%
performance
11%
curves
11%
auc
10%
probability
10%
calibration
10%
toxicity
8%
trains
8%
larynx
7%
pharynx
7%
biopsy
6%
hazards
6%
algorithms
6%
computer codes
6%
pathology
6%
WHO
6%
epithelium
6%
comparative evaluations
5%
metastases
5%
radiotherapy
5%
management
5%
prediction
5%
assessments
5%
metrics
5%
utilities
5%
evaluation
5%
sensitivity
5%
specificity
5%
risks
5%
Keyphrases
Head-and-neck Cancer
100%
Advanced Stage
40%
Chemoradiotherapy
29%
HPV Negative
25%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
25%
QuPath
20%
Dose-response Model
20%
Disease-associated
20%
Dysphagia
20%
Disease Outcome
20%
Ontology
20%
Digital Image Analysis
20%
Cancer Data
20%
Tumor-infiltrating
20%
Integrative Research
20%
Cancer Patients
20%
Privacy-preserving
20%
Platinum-based
20%
Proton Therapy
20%
Multi-centered
20%
Prognostic Value
20%
Findable
20%
CD57
20%
Personal Health Train
16%
Clinical Data
15%
Closed Testing Procedure
12%
Cisplatin
10%
Overall Survival
10%
Clinical Variables
8%
Federated Learning
8%
Normal Tissue Complication Probability Models
8%
Revised Model
8%
Pharynx
7%
Patient Cohort
6%
Multicenter Cohort
6%
Cisplatin Toxicity
6%
Distant Metastasis
6%
Clinical Management
6%
Stage III-IV
6%
Human Observer
5%
Medicine and Dentistry
Head and Neck Cancer
60%
Disease
23%
Chemoradiotherapy
23%
Plummer-Vinson Syndrome
20%
Proton Therapy
20%
Cisplatin
20%
Dose Response
20%
Head and Neck Squamous Cell Carcinoma
14%
Overall Survival
8%
Larynx
6%
Pharynx
6%
Distant Metastasis
5%
Clinical Management
5%
